India's health report reads worse (GS-2) Indians have registered a 50% increase in the prevalence of ischemic heart diseaseand stroke over the period from 1990 to 2016, with the number of diabetes cases climbing from 26 million to 65 million. In the same period, the number of people ailing from chronic obstructive lung disease went up from 28 million to 55 million, according to the India State-level Disease Burden Initiative' report released on Wednesday. The proportional contribution of cancers to the total loss of health in India has doubled from 1990 to 2016, but the incidence of different types of cancers varies widely between the States Joint initiative The report is a joint initiative of the Indian Council of Medical Research (ICMR), the Public Health Foundation of India (PHF) and the Institute for Health Metrics and Evaluation (IHME) in collaboration with the Ministry of Health and Family Welfare, along with experts and stakeholders associated with over 100 Indian institutions. * The State-wise disease burden showed that Punjab has been ranked at the top for the burden of ischemic heart disease followed by Tamil Nadu, and vice-versa for diabetes. West Bengal topped with the largest number of stroke cases followed by Odisha, according to the comprehensive analysis of several major non-communicable diseases (NCDs).
Prevalence of ischemic heart disease and stroke has increased by over 50% from 1990 to 2016 in India, with an increase abserved in every State Worryin trends Number of persons Number of chronic obstructive lung with diabetes in India dlsease cases In Indla has Increased has increased from 26 millilon In 1990 to to 2016, and the death rate among 65 million in 2016 from 2B million to 55 million from 1990 these cases is twice as high in the ess- developed States - Rate of increase In the burden of ischemic heart disease and diabetesfrom 1990 to 2016, but the incidence of has been the highest different types of cancers varies widely In the less developed betwen the States States of India, where the burden of uicde is the leading cause of death in chronic obstructive lung disease and infectious conditions has increased over the past quarter is already high Proportional contribution of cancers to the total health loss in India has doubled the 15-39 years age group In Indla, and the suicide death rate among the elderly century
* Kerala was ranked at the top for the burden of cancer, followed by Assam. Being overweight was found to be a major risk factor for diabetes doubled in every State of India from 1990 to 2016. The findings have been reported in a series of five research papers published in The Lancet Global Health, The Lancet Public Health, and 'The Lancet Oncology', along with a commentary in the medical journal The Lancet. Professor Balram Bhargava, Secretary, Department of Health Research, Ministry of Health and Family Welfare, and Director General, ICMR, said: "These papers, through detailed analysis, have elucidated disease and risk factor trends for major NCDs, and suicides, in every State, over 26 years." He added that while it is known that NCDs have been increasing in India, a major finding of concern is that the highest rate of increase in ischemic heart disease and diabetes is in the less developed States of India. "These States already have a high burden of chronic obstructive lung disease, and of a range of infectious and childhood diseases, so the control of NCDs in these States has to be boosted without delay," he said. The papers showed that the proportional contribution of cancers to disease burden in India has doubled since 1990, but the incidence of individual cancers varies widely between the States, the reasons for which need to be understood better to guide prevention and control of cancer.
Ayushman Bharat Experts noted that the insights provided by these findings are very timely for the planning of Ayushman Bharat, the National Health Protection Mission announced recently by the Prime Minister. "ICMR is also working at creating a standard treatment workflow for Ayushman Bharat," said Dr. Bhargava. The Council added that they are all set to make public Mahatma Gandhi's health records general health, blood pressure data, etc. as part of the 150th commemorative issue of the Indian Journal of Clinical Research
37% of women dying of suicide are Indians (GS-1/2/3) Suicide is the leading cause of death in the l 5-39 years age group in India Thirty-seven per cent of such deaths among women globally occur in India, and the suicide rate among the elderly has increased over the past quarter century The data was released on Wednesday by the India State-level Disease Burden Initiative, a joint study of the Indian Council of Medical Research (ICMR) and other institutes including the Public Health Foundation of India and the Institute for Health Metrics and Evaluation in collaboration with the Ministry of Health and Family Welfare. Prevention strategy "India's proportional contribution to global suicide deaths is high and increasing. Suicide Death Rate (SDR) in India is higher than expected for its socio-demographic index level, especially for women, with substantial variations in the magnitude and men-to-women ratio between the states," the study noted
India must develop a suicide-prevention strategy that takes into account these variations in order to address this major public health problem, it stated."The highest age-specific SDR among women in 2016 was for ages 15-29 years. Suicide was the leading cause of death in India in 2016 for those aged 15-39 years; 71.2% of the suicide deaths among women and 57.7% among men were in this age group," the study said ICMR Director-General Balram Bhargava said: "The very high contribution of India-from 1990 to 2016-to the total suicide deaths in the world, especially among women, is a cause of worry.The ten-fold variation between the States in the SDR for women emphasises the need to better understand the reasons behind these suicides and make concerted efforts to reduce this avoidable loss of predominantly young lives." A. "India's contribution to global suicide deaths increased from 25.3% in 1990 to 36.6% in 2016 among women, and from 18.7% to 24.3% among men," the study noted. It further said that if the trends observed up to 2016 continued, the probability of India achieving Sustainable Development Goals for SDR reduction in 2030 was zero. Andhra Pradesh, Karnataka,Tamil Nadu, and Telangana, which are in the higher-middle and high epidemiological transition level groups, consistently had a higher SDR for both men and women.
Curbs on 328 Fixed Dose Combinations (GS-2/3) The Ministry of Health and Family Welfare has prohibited the manufacture for sale, sale or distribution for human use of 328 Fixed Dose Combinations (FDCs) with immediate effect, according to a direction issued here orn Wednesday. It also restricted the manufacture, sale or distribution of six FDCs subject to certain condition:s. "Earlier, the Central government had, through its notifications published on the 10th March, 2016, in the Gazette of India, prohibited the manufacture for sale, sale and distribution for human use of 344 FDCs under Section 26 A of the Drugs and Cosmetics Act, 1940. Subsequently, the government had prohibited five more FDCs in addition to the 344 under the same provisions," said a Ministry release. However, the matter was contested by manufacturers in various High Courts and the Supreme Court. In compliance with the Supreme Court judgment dated December 15,2017, the matter was examined by the Drugs Technical Advisory Board which gave its report to the Central
* Combination products, also known as fixed dose drug combinations (FDCs), are combinations of two or more active drugs in a single dosage form. The Food and Drug Administration, USA defines a combination product as a product composed of any combination of a drug and a device or a biological product and a device or a drug and a biological product or a drug, device, and a biological product' It is widely accepted that most drugs should be formulated as single compounds. Fixed ratio combination products are acceptable only when the dosage of each ingredient meets the requirement of a defined population group and when the combination has a proven advantage over single compounds administered separately in therapeutic effect, safety or compliance
FDCs are highly popular in the Indian pharmaceutical market and have been particularly flourishing in the last few years. The rationality of FDCs should be based on certain aspects such as I. The drugs in the combination should act by different mechanisms. 2. The pharmacokinetics must not be widely different. 3. The combination should not have supra-additive toxicity of the ingredients. Most FDCs have the following demerits: I. Dosage alteration of one drug is not possible without alteration of the other drug. 2. Differing pharmacokinetics of constituent drugs pose the problem of frequency of administration of the formulation. 3. By simple logic there are increased chances of adverse drug effects and drug interactions compared with both drugs given individually
Want cheaper fuel? Visit this border outpost in Bhutan (GS-2/3) Decades of informal trade between Assam and Bhutan, disrupted by insurgency, took a formal shape with the inauguration of a border trade centre at Darranga on Wednesday. About 90 km north of Guwahati, Darranga in Baksa district under Bodoland Territorial Council (BTC) adjoins Samdrup Jongkhar, a major trade point in southern Bhutan. Besides oranges and potatoes, Bhutan exports some items produced by five industrial units near Samdrup Jongkhar. They include gypsum, ferro-silicon and iron nails. Attraction: cheap fuel For Indians the real big attraction across the border is not iron and nails but is fuel-ironically imported from India. A litre of diesel and petrol in Bhutan averages?54 and 59 respectively, about?20-25 cheaper than the nearest oil outlet in Assam, where a litre of diesel is about 275 and petrol is 84.
Graduate in Economics. Gold medal in Dissertation, Prepared various documents on Demonetisation and GST, Share-trading and many more